Whereas, Angelman syndrome is a rare neuro-genetic disorder that occurs in one in every 15,000 live births or 500,000 people worldwide; and
Whereas, Angelman syndrome shares symptoms and characteristics with other disorders including autism, cerebral palsy, and Prader-Willi syndrome, often leading to misdiagnosis; and
Whereas, Individuals diagnosed with Angelman syndrome have developmental problems that become noticeable by the age of 6-12 months; and
Whereas, Common signs and symptoms usually appear in early childhood like walking and balance disorders, gastrointestinal issues, seizures, and little to no speech; and
Whereas, Life expectancy of individuals with Angelman syndrome is normal and itself does not cause death; and
Whereas, Despite its symptoms, people with Angelman syndrome have an overall happy and excitable demeanor; and
Whereas, It is critical for the success of research and support services that we raise awareness in the general public and the medical community about Angelman syndrome; now, therefore, be it
Resolved by the Senate, That the members of this legislative body designate February 15, 2024, as Angelman Syndrome Awareness Day.
Co-sponsored by Sens.
Adopted in the Senate by voice vote